You are viewing: China Theranostics Market analysis
Part of: Theranostics Market (Global)

The China Theranostics Market was valued at $131.2 Million in 2023 and projected to reach to $346.5 Million by 2028, representing a compound annual growth rate of 21.4%. China's theranostics market is positioned for exceptional growth through 2028, driven by escalating cancer prevalence, government healthcare modernization initiatives, and substantial R&D investments in precision medicine.

China Theranostics Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Theranostics Market Trends and Insights

  • This exceptional growth trajectory reflects China's substantial investments in precision medicine infrastructure and diagnostic innovation.
  • China is leveraging advanced imaging technologies and targeted therapeutic solutions to address rising cancer incidence and chronic disease prevalence across its population. The theranostics sector in China benefits from government support for healthcare modernization and increased adoption of personalized medicine approaches.
  • China's pharmaceutical and medical device industries are increasingly integrating diagnostic and therapeutic capabilities into single platforms.
  • By 2028, China is expected to solidify its position as a leading theranostics market in the Asia Pacific region, driven by expanding healthcare access, growing patient awareness, and accelerating clinical adoption of theranostic agents. China's competitive advantage stems from its large patient population, manufacturing capabilities, and regulatory reforms that expedite approval pathways.
  • China continues to attract significant R&D investment from both domestic and international theranostics companies seeking to capitalize on this high-growth market opportunity..

Key Market Statistics

  • CAGR (2023-2028) 21.4% CAGR
  • Market Size, 2023 ~USD 131.2 Million
  • Forecast, 2028 ~USD 346.5 Million
  • Country China

China Theranostics Market Overview

Rapid Market Expansion :

China's theranostics market is projected to grow from $131.2 million in 2023 to $346.5 million by 2028, representing a robust 21.4% CAGR—significantly outpacing the global average of 15.5%.

Government-Backed Precision Medicine :

China's substantial investments in precision medicine infrastructure and diagnostic innovation are driving market growth, supported by national healthcare policies prioritizing advanced medical technologies.

Cancer Management Focus :

Rising cancer incidence in China is accelerating demand for integrated theranostic solutions that combine advanced imaging technologies with targeted therapeutic interventions for improved patient outcomes.

Technology Integration Leadership :

Chinese healthcare providers are increasingly adopting combined diagnostic-therapeutic platforms, leveraging cutting-edge imaging and molecular targeting to enhance treatment efficacy and personalization.

China Theranostics Market Dynamics

  • The country's expanding middle class and improving healthcare accessibility are creating robust demand for advanced diagnostic-therapeutic solutions.
  • Major pharmaceutical and medical device companies are establishing regional hubs in China to capitalize on this high-growth opportunity, while domestic innovators are developing localized theranostic platforms tailored to Chinese patient populations and healthcare infrastructure..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • SANOFI
  • Merck KGaA
  • NOVARTIS
  • Pfizer Inc.

    Key Takeaways

    • China's theranostics market is projected to grow from $131.2 million in 2023 to $346.5 million by 2028, representing a 21.4% CAGR.
    • China's government-backed precision medicine initiatives and healthcare modernization policies are primary catalysts for theranostics adoption.
    • China's large patient population and rising cancer prevalence create substantial demand for integrated diagnostic-therapeutic solutions.
    • China is attracting significant domestic and international R&D investment, positioning it as a key growth engine in the Asia Pacific theranostics market.

    Theranostics Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment THERANOSTICS CENTERS (End User)
    Forecast Period 2023-2028
    Growth Rate CAGR of 15.5% from 2023 to 2028
    Largest Segment RADIOPHARMACEUTICALS (Product)
    Market Size Base Year (Billions) ~USD 2.09 (2023)
    Revenue Forecast (Billions) ~USD 4.3 (2028)
    Segments Covered Product, Type, Application, End User

    China Theranostics Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Imaging
    • Ivd/Biomarker Screening
    • Radiopharmaceuticals
    • Software & Services

    By Type

    • Iodine-131
    • Lutetium-177
    • Other Radiopharmaceuticals
    • Radium-223
    • Samarium-153
    • Yttrium-90

    By Application

    • Bone Metastasis
    • Other Applications
    • Other Cancer
    • Other Cancers
    • Prostate Cancer

    By End User

    • Hospitals And Cancer Care Centers
    • Research And Academic Centers
    • Theranostics Centers

    Target Audience

    • Pharmaceutical Companies : Evaluate China's theranostics market potential for drug development pipelines, companion diagnostic partnerships, and regional commercialization strategies targeting precision oncology applications.
    • Medical Device Manufacturers : Assess market opportunities for diagnostic imaging systems and therapeutic delivery platforms in China, including regulatory pathways, reimbursement models, and healthcare provider adoption rates.
    • Healthcare Investors & PE Firms : Analyze China's theranostics sector for investment opportunities, growth trajectories, and exit strategies, with detailed market sizing and competitive dynamics to support portfolio decisions.
    • Hospital & Diagnostic Centers : Understand theranostics market trends, technology options, and patient demand in China to optimize service offerings, procurement strategies, and precision medicine program development.
    • Healthcare Consultants & Strategists : Access China-specific market intelligence for client advisory work, competitive benchmarking, and strategic planning in precision medicine, oncology, and diagnostic innovation sectors.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China's theranostics sector with detailed CAGR projections through 2028, enabling accurate financial forecasting and investment decision-making for regional expansion strategies.
    • Competitive Landscape Intelligence : Understand China-specific market dynamics, key players, and competitive positioning to identify partnership opportunities, acquisition targets, and market entry strategies in this high-growth healthcare segment.
    • Regulatory & Policy Insights : Access comprehensive analysis of China's precision medicine policies, healthcare regulations, and government initiatives driving theranostics adoption, critical for compliance and market strategy development.
    • Cancer Incidence Correlation : Leverage detailed epidemiological data linking rising cancer rates in China to theranostics demand, enabling targeted marketing, product development, and clinical trial planning aligned with patient needs.
    • Technology Adoption Trends : Identify emerging imaging technologies and therapeutic platforms gaining traction in Chinese healthcare systems, informing product innovation roadmaps and commercialization strategies for maximum market penetration.

    Frequently asked questions

    What is the current size of China's theranostics market?

    China's theranostics market was valued at $131.2 million in 2023 and is expected to grow to $346.5 million by 2028.

    What is the projected CAGR for China's theranostics market?

    China's theranostics market is projected to grow at a compound annual growth rate (CAGR) of 21.4% from 2023 to 2028.

    What are the main drivers of growth in China's theranostics market?

    Key growth drivers include government support for precision medicine, rising cancer incidence, healthcare modernization initiatives, regulatory reforms, and increasing adoption of personalized medicine approaches.

    How does China's theranostics market compare to other Asia Pacific countries?

    China is emerging as a leading theranostics market in Asia Pacific, driven by its large patient population, manufacturing capabilities, and accelerating clinical adoption of theranostic agents.

    What types of theranostic applications are most prevalent in China?

    Cancer diagnostics and treatment, chronic disease management, and advanced imaging-guided therapeutic interventions represent the primary theranostic applications in China's healthcare system.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the theranostics market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial theranostics market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as OEMs, CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the theranostics market. The primary sources from the demand side include medical CDMOs, oncologists, doctors, radiologists, technicians, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Theranostics Market Size, and Share

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Estimation Methodology

    In this report, the theranostics market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insigh ts gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

    Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

    • Generating a list of major global players operating in the theranostics market.
    • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
    • Revenue mapping of major players to cover a major share of the global market share, as of 2022
    • Extrapolating the global value of the theranostics market industry

    Theranostics Market Size, and Share

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global theranostics market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using top-down and bottom-up approaches.

    Market Definition

    Theranostics is a term used for diagnosis and therapy. Theranostics can be broadly defined as a combination of molecularly targeted imaging and therapy, whereas imaging helps to gain information regarding presence of targeted moleculaes on cell surface and therapy progression. Radiotheranostics involves the use of radionuclide/radiopharmaceutical that delivers targeted radiation to kill the cancerous cells and imaging modality such as positron emission tomography (PET) is used to locate the cancer.  FDA approved theranostics procedures are performed for different applications such as prostate cancer, neuroendocrine tumor, etc. These procedures are mainly performed in hospitals, cancer care centers, and  theranostics centers.

    Key Stakeholders

    • Senior Management
    • End Users
    • R&D Department
    • Finance/Procurement Department

    Objectives of the Study

    • To define, describe, and forecast the size of theranostics market based on product, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)  
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market.   
    • To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to three major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and Rest of the World (Latin America and Middle East and Africa).
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
    • To track and analyze the competitive developments undertaken in the global market, such as product launches; agreements; expansions; and mergers & acquisitions.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global theranostics market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top fifteen companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographic Analysis

    • Further breakdown of the Rest of Europe theranostics market into Italy, Spain Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific theranostics market into Australia, South Korea, Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries

    Get the Full Theranostics Market Report

    Full forecast, segment splits, and company analysis for all Theranostics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status